0 608

Cited 6 times in

Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

DC Field Value Language
dc.contributor.author강은석-
dc.contributor.author김규리-
dc.contributor.author남정모-
dc.contributor.author이병완-
dc.contributor.author이용호-
dc.contributor.author이지연-
dc.contributor.author차봉수-
dc.date.accessioned2019-09-20T07:32:58Z-
dc.date.available2019-09-20T07:32:58Z-
dc.date.issued2019-
dc.identifier.issn1262-3636-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/170945-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish, French-
dc.publisherMasson-
dc.relation.isPartOfDiabetes & Metabolism-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAged-
dc.subject.MESHCarcinoma, Hepatocellular/epidemiology-
dc.subject.MESHCarcinoma, Hepatocellular/etiology*-
dc.subject.MESHFemale-
dc.subject.MESHGliclazide/adverse effects*-
dc.subject.MESHHumans-
dc.subject.MESHHypoglycemic Agents/adverse effects*-
dc.subject.MESHIncidence-
dc.subject.MESHLiver Neoplasms/epidemiology-
dc.subject.MESHLiver Neoplasms/etiology*-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHRisk-
dc.subject.MESHSulfonylurea Compounds/adverse effects*-
dc.titleComparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorJ.-Y. Lee-
dc.contributor.googleauthorG. Kim-
dc.contributor.googleauthorY.-H. Lee-
dc.contributor.googleauthorB.-W. Lee-
dc.contributor.googleauthorB.-S. Cha-
dc.contributor.googleauthorC.M. Nam-
dc.contributor.googleauthorE.S. Kang-
dc.identifier.doi10.1016/j.diabet.2017.06.007-
dc.contributor.localIdA00068-
dc.contributor.localIdA00322-
dc.contributor.localIdA01264-
dc.contributor.localIdA02796-
dc.contributor.localIdA02989-
dc.contributor.localIdA03197-
dc.contributor.localIdA03996-
dc.relation.journalcodeJ00719-
dc.identifier.eissn1878-1780-
dc.identifier.pmid28778564-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S1262363617304718-
dc.contributor.alternativeNameKang, Eun Seok-
dc.contributor.affiliatedAuthor강은석-
dc.contributor.affiliatedAuthor김규리-
dc.contributor.affiliatedAuthor남정모-
dc.contributor.affiliatedAuthor이병완-
dc.contributor.affiliatedAuthor이용호-
dc.contributor.affiliatedAuthor이지연-
dc.contributor.affiliatedAuthor차봉수-
dc.citation.volume45-
dc.citation.number1-
dc.citation.startPage83-
dc.citation.endPage85-
dc.identifier.bibliographicCitationDiabetes & Metabolism, Vol.45(1) : 83-85, 2019-
dc.identifier.rimsid64358-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.